| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |